In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.  Subscribe to Eagle’s Eye View  

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking science from the American Heart Association Scientific Sessions 2023 including ESPIRIT (0:34), MINT (3:54), ORFAN (8:25), ARISE and STREAM-2 (11:23).  The ACC is providing coverage of the latest science being presented at the AHA Scientific Sessions in Philadelphia. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page linked here.  Follow the ACC on Social...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from day 2, Sunday, November 12 at the American Heart Association Scientific Sessions 2023 including AZAELEA-TIMI 71 (0:38), ARTESIA (5:07) and REPRIEVE (7:52).  The ACC is providing coverage of the latest science being presented at the AHA Scientific Sessions in Philadelphia. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page linked...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the first day of late-breaking clinical trials at AHA 2023 for Saturday, November 11, including SELECT (0:35), DAPA MI (4:17), and ORBITA2 (7:45).   Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle explores the impact of residual ischemia on cardiovascular mortality in left main bifurcation stenting. He then discusses coronary revascularization guided by instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality. Finally, Dr. Eagle examines dyspnea-related ticagrelor discontinuation after percutaneous coronary intervention.  Subscribe to Eagle’s Eye View  

In this special edition of the View, Dr. Eagle summarizes the top science that will be presented at AHA 2023 from November 11 to November 13 in Philadelphia.    Dr. Eagle shares some of the trials that have captured attention, including:  SELECT, that investigates semaglutide and cardiovascular outcomes in non-diabetic patients who are overweight or obese;  ORBITA-2, a randomized trial that evaluates PCI for Stable Angina; DAPA-MI, a registry-based randomized trial examining the effects...

Drs. Dharam Kumbhani, Ki Park, and Ajay Kirtane review the late-breaking clinical trials from Thursday, October 26 at TCT 2023 including RADIANCE (0:44) and TRILUMINATE (3:32). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (linked here) Follow the ACC on Social Media (linked here) and use the hashtag #TCT2023.  (https://twitter.com/hashtag/TCT2023).   Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle explores a UK Biobank study on triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease. He then discusses the risk of atrial and ventricular arrhythmia comparing carvedilol versus metoprolol among implantable cardioverter defibrillator recipients. Finally, Dr. Eagle examines the results from the ORION-5 randomized clinical trial that looked at the efficacy, safety, and tolerability of inclisiran in patients with...

Drs. Dharam Kumbhani, Ki Park, and Ajay Kirtane review the late-breaking clinical trials from Wednesday, Oct. 25 at TCT 2023, including AGENT IDE (0:45), T-PASS (3:44), and SWEDEHEART (6:50).  For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (linked here) Follow the ACC on Social Media (linked here) and use the hashtag #TCT2023.  (https://twitter.com/hashtag/TCT2023).    Subscribe to Eagle’s Eye View  

Drs. Dharam Kumbhani, Ki Park, and Ajay Kirtane review the late-breaking clinical trials from Tuesday Oct. 24 at TCT 2023 including PARTNER 3 (0:45) and Evolut (4:36). The ACC is providing coverage of the lates-breaking clinical science being presented at TCT 2023 in San Francisco. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (linked here) Follow the ACC on Social Media (linked here) and use the hashtag #TCT23...

In this special edition of the View, Dr. Eagle summarizes the top science that will be presented at TCT 2023 from October 23rd to October 26th in San Francisco.   Dr. Eagle shares some of the trials that have captured attention, including: Four Year Outcomes from the EVOLUT Low Risk Trial, Five-Year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low Risk Randomized Trial, Less-Than One-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug...

In this week’s View, Dr. Eagle explores the role of one- or three-month DAPT in HBR patients with or without oral anticoagulant therapy after PCI. He then discusses a meta-analysis of the co-administration of mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure. Finally, Dr. Eagle examines the use of PET imaging in following patients with giant cell arteritis.   Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle explores the efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure. He then discusses the performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in clinical practice. Finally, Dr. Eagle examines JACC’s State-of-the-Art Review of antithrombotic therapy for primary and secondary prevention of ischemic stroke.   Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle explores the benefits and drawbacks of vegetarian and vegan diets. He then discusses LDL cholesterol reduction for primary prevention of major vascular events in the elderly. Finally, Dr. Eagle examines the lack of association between fluoroquinolone and aortic aneurysm or dissection.   Subscribe to Eagle’s Eye View  

This week’s Eagle’s Eye View is dedicated to a beloved member of the ACC community,  Steve Kerchner. Steve in many ways has been the face, heart and driving force behind the College’s digital transformation.  We lost Steve last week after a valiant battle with cancer. He will always be part of our community at ACC.org.    In this week’s View, Dr. Eagle explores the efficacy of early catheter ablation for atrial fibrillation after admission for heart failure. He then discusses the...

In this week’s View, Dr. Eagle explores the associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. He then discusses a study that looks at stroke risk in women with atrial fibrillation. Finally, Dr. Eagle examines the DCM Precision Medicine Study of rare variant genetics and dilated cardiomyopathy severity.   Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle explores the association of coronary artery calcium detected by routine ungated CT imaging with cardiovascular outcomes. He then discusses the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves. Finally, Dr. Eagle reviews a mechanistic study on atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events.   Subscribe to Eagle’s Eye View  

In this special edition of the View, Dr. Eagle summarizes the top trials that were presented at the ESC Congress in Amsterdam from Friday, Aug. 25 through Monday, Aug. 28.    Dr. Eagle discusses STEP-HFpEFF, evaluating the targeting of therapy in patients with the obesity phenotype and heart failure with preserved ejection fraction. He then looks at STOP-DAPT3 exploring the benefit of the prasugrel monotherapy without aspirin as compared with the 1-month dual therapy with aspirin and...

In this special edition of the View, Kim A. Eagle, MD, MACC, talks with Dharam J. Kumbhani, MD, SM, FACC, Philippe Gabriel Steg, MD, FACC, and Payal Kohli, MD, FACC, about three of the major trials presented Monday, Aug. 28 during ESC Congress 2023.   The trials include ARAMIS (0:39), investigating potential treatments for acute myocarditis, RIGHT (3:22), exploring STEMI patients treated with primary PCI, evaluating the prolongation of anticoagulation after the procedure and ONCO-DVT...

In this special edition of the View, Kim A. Eagle, MD, MACC, talks with Dharam J. Kumbhani MD, SM, FACC, Philippe Gabriel Steg, MD, FACC, and Payal Kohli, MD, FACC, about four of the major trials that were presented on Day 3 of the ESC Congress in Amsterdam on Sunday, Aug. 27.   The trials include ATTRIBUTE-CM (00:39), investigating the efficacy and safety of acoramidis in subjects with symptomatic transthyretin amyloid cardiomyopathy (ATTR-CM). MULISTARS (03:15), investigating patients...

 In this special edition of the View, Kim A. Eagle, MD, MACC, talks with Philippe Gabriel Steg, MD, FACC, and Payal Kohli, MD, FACC, about four of the major trials that were presented on Day 2 of the ESC Congress in Amsterdam on Saturday, Aug. 26. The trials include ECLS-SHOCK (0:44) that investigates extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock, CLEAR-Outcomes (03:34), looking at bempedoic acid and cardiovascular outcomes in...

In this special edition of the View, Dr. Eagle talks with Dharam J. Kumbhani MD, SM, FFACC, MACC, Philippe Gabriel Steg MD, and Payal Kohli MD about four of the major trials that were presented on Day 1 of the ESC Congress in Amsterdam on Friday, August 25. The trials include COP-AF (0:40), exploring colchicine for the prevention of perioperative atrial fibrillation in patients undergoing thoracic surgery, BIOFLOW DAPT (3:18), a prospective, randomized, multicenter study to assess the safety...

In this week’s View, Dr. Eagle explores the impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on the recurrence of atrial fibrillation after catheter ablation in patients with type-2 diabetes, then discusses the differences and similarities between the ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases. Finally, Dr. Eagle looks at data from the VICTORIA Trial and asks whether age or sex affect the outcome of patients with heart failure with reduced...

In this special edition of the View, Dr. Eagle discusses some of the major trials and guidelines that are at the center of this year’s ESC Congress 2023, taking place in Amsterdam from Friday, August 25 to Monday, August 28.  ACC.org will be covering all the high points of this year’s Congress, including late-breaking trials with a special focus on interventional cardiology, as well as major papers on atrial fibrillation, heart failure, shock, and much more.   Among the trials that...

In this week’s View, Dr. Eagle explores what cardiologists should know about migraine and cardiovascular disease. Dr. Eagle then looks at microvascular resistance reserve and its diagnostic and prognostic performance in the ILIAS registry.  Subscribe to Eagle’s Eye View